WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'1701 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 9'7361 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 21'273  21'098  20'926  20'759  20'602  18'846  17'324  15'033 
Births 380  383  384  384  383  350  357  405 
Surviving infants 377  379  381  380  379  345  349  392 
Pop. less than 5 years 1'883  1'874  1'864  1'854  1'844  1'661  1'779  1'909 
Pop. less than 15 years 5'353  5'304  5'256  5'215  5'179  5'063  5'558  5'395 
Female 15-49 years 5'486  5'489  5'491  5'490  5'492  5'208  4'537  3'750 

Number of reported case

(Click for retrospective incidence data for Sri Lanka)
Diphtheria 37 
Japanese encephalitis 70  60  30  27  72 
Measles 2'107  51  60  79  21  16'527  4'004  5'032 
Mumps 1'274  3'558  1'129  897  660  901 
Pertussis 67  61  23  31  194  271  542 
Polio* 264 
Rubella 24  54  416  68  143  29 
Rubella (CRS) 12  26 
Tetanus (neonatal) 339 
Tetanus (total) 19  14  11  18  97  183  1'243 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sri Lanka)
Vaccine year result method % card seen                                                
BCG 2006  100  DHS   93  99  99  99  99  99  99*  84  61 
DTP1 2006  100  DHS   93  99  99  99  99  97  96 
DTP3 2006  99  DHS   93  99  99  99  99  97  99*  86  46 
HepB_BD         
HepB3          99  99  99  99  97 
Hib3          99  99  99  99 
JapEnc          99  99  95  95  64 
MCV 2006  97  DHS   93  99  99  99  99  97  99  80 
MCV2          99  99  99  99  97 
PCV1         
PCV3         
Pol3 2006  99  DHS   93  99  99  99  99  97  99*  86  46 
Rota1         
Rota_last         
Rubella1          99  99  99  97 
TT2plus 1992  65  DHS     99  99  99  99  97  99*  68  50 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sri Lanka)
BCG 99  99  99  99  99  98  84  61 
DTP1 99  99  99  99  97  99  95  71 
DTP3 99  99  99  99  97  99  86  46 
HepB3 99  99  99  99  97 
HepB_BD
Hib3 99  99  99  99 
MCV 99  99  99  99  97  99  80 
MCV2 99  99  99  99  97 
PAB 95  95  95  86  93  92  72  45 
PnC3
Pol3 99  99  99  99  97  99  86  46 
Rota_last

Number of districts in the country 26  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 5 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
JapEnc 9 months; Yes
MMR 1, 3 years; Yes
OPV 2, 4, 6, 18 months; 5 years; Yes
TT During pregnancies; Yes
Td 12 years; Yes
Typhoid high risk groups
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2016    2012 - 2017  2007 - 2011  2007-2011  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 26  26  26  26  26  26  26 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 26  26  26  26  26  26  26 
Nº districts with DTP3 coverage >=80% number 26  25  26  26  24  26 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  96  100  100  92  100 
Nº districts with measles (MCV1) coverage >=95% number 15  17  16  14  24  23   
% of districts with MCV1 coverage >=95% From 0 to 100% 58  65  62  54  92  88   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 41    39  57  100  90  31 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.